Research and Policy Repository

  • Author: Zohra Nooruddin
Clear all

Shift in first-line therapies for United States Veterans Affairs (VA) patients with chronic lymphocytic leukemia (CLL)

Abstract: Chronic lymphocytic leukemia (CLL) is a prevalent but incurable malignancy with a variable disease course. As the most common lymphoid malignancy in the United States, …

Physical Health Peer reviewed

The Impact of Race and Ethnicity on Diffuse Large B-Cell Lymphoma Outcomes within the Veterans Health Administration (VHA)

Abstract: We performed a retrospective chart review of 6266 randomly selected DLBCL patients treated in the VHA nationwide between 1/1/2011 and 12/31/2021. The 3178 patients who …

Physical Health Peer reviewed

Clinical characteristics, treatment patterns, and outcomes of patients with locally advanced/metastatic hepatocellular carcinoma treated at the Veterans Health Administration

Abstract: Purpose This study retrospectively reviewed the outcomes of patients with advanced hepatocellular carcinoma (HCC) receiving atezolizumab with bevacizumab (A + B) therapy …

Physical Health Peer reviewed

Survival outcomes of diffuse large B cell lymphoma beyond the rituximab era: Comprehensive analysis of a veteran population within the Veterans Health Administration over 11 years

Abstract: Introduction: The standard treatment approach for DLBCL has traditionally relied on chemo-immunotherapy with R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine …

Physical Health Peer reviewed

Incidence of invasive fungal infections in patients with chronic lymphocytic leukemia receiving ibrutinib within the Veteran's Healthcare Administration

Abstract: Purpose: Ibrutinib is a tyrosine kinase inhibitor that is increasingly prescribed in chronic lymphocytic leukemia (CLL). Invasive fungal infections (IFIs) have been …

Physical Health Peer reviewed